Retrospective Observational Study Evaluating Efficacy of Saroglitazar 4mg in Type 2 Diabetic Dyslipidemic Patients at Tertiary Care Centre in India.
- Resource Type
- Article
- Source
Atherosclerosis (Supplements) . Jun2018, Vol. 32, p47-47. 1p.- Subject
- *
PEROXISOME proliferator-activated receptors
*DRUG efficacy
*DYSLIPIDEMIA
*TYPE 2 diabetes
*MEDICAL care
*THERAPEUTICS - Language
- ISSN
- 1567-5688